Karachi
April 8, 2021
The federal government has allocated an amount of $150 million for procurement of safe and effective life-saving Covid-19 vaccines to immunise the eligible population in the country with a special focus on the most vulnerable segments, a deputy director of the federal ministry of health services told the Sindh High Court (SHC) on Tuesday.
Filing comments on a court query with regard to general import of Covid-19 vaccines in the country, the federal health ministry official submitted that no serious adverse event had so far been reported in Pakistan after almost 850,000 inoculations given to different priority groups till date, including elderly populations.
CanSinoBIO Announces Approval for its Single-Dose COVID-19 Vaccine Convidecia in Chile finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Safe, stable storage and transportation between 2°C and 8°C, accessible by under-developed regions
95.47% effective overall in preventing severe COVID-19 diseases 14 days after vaccination
TIANJIN, China, April 8, 2021 /PRNewswire/ CanSino Biologics Inc. ( CanSinoBIO ) (HKEX: 06185) today announced that the Instituto de Salud Pública de Chile ( ISP ) granted emergency use authorization for its Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) ( Ad5-nCoV , trade name: Convidecia™). This marks the first approval of Convidecia™ in South America and the first single-dose COVID-19 vaccine approved for emergency use in Chile.
On February 25, 2021, Convidecia™ was granted a conditional marketing authorization by the National Medical Products Administration of China ( NMPA ), the first of its kind authorized in China. Globally, Convidecia™ received authorization for emergency use by the Hungarian National Institute of Pharmacy and Nutrition (OGYÉI) in Ma
CanSinoBIO Announces Approval for its Single-Dose COVID-19 Vaccine Convidecia™ in Chile prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Al-Shifa begins final trials of Chinese Covid vaccine
April 7, 2021
Final trials of coronavirus vaccine developed by Chinese multinational Anhui Zhifei Longcom Biopharmaceutical Co Ltd has been initiated at the Al-Shifa Trust Eye Hospital, after which it will be made available to the public across Pakistan.
The vaccine has already been approved by the government of China, while trials have started at Al-Shifa after Drug Regulatory Authority of Pakistan (DRAP) recommended its Rawalpindi facility for the purpose. After successful completion of phase 1 and phase 2 of the trials, the third and final phase was launched on Tuesday after the signing of an agreement between Al-Shifa Trust and the Chinese company.